William Blair Investment Management LLC Acquires 124,396 Shares of Merit Medical Systems, Inc. $MMSI

William Blair Investment Management LLC grew its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 16.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 863,996 shares of the medical instruments supplier’s stock after acquiring an additional 124,396 shares during the period. William Blair Investment Management LLC’s holdings in Merit Medical Systems were worth $71,910,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Assenagon Asset Management S.A. bought a new position in Merit Medical Systems in the 3rd quarter worth $1,644,000. Norges Bank bought a new position in shares of Merit Medical Systems in the second quarter worth about $53,697,000. Fort Washington Investment Advisors Inc. OH raised its stake in shares of Merit Medical Systems by 69.7% in the third quarter. Fort Washington Investment Advisors Inc. OH now owns 301,718 shares of the medical instruments supplier’s stock worth $25,112,000 after buying an additional 123,912 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of Merit Medical Systems by 5.3% during the 2nd quarter. Envestnet Asset Management Inc. now owns 244,163 shares of the medical instruments supplier’s stock valued at $22,824,000 after buying an additional 12,256 shares in the last quarter. Finally, Westwood Holdings Group Inc. grew its stake in shares of Merit Medical Systems by 11.9% during the 2nd quarter. Westwood Holdings Group Inc. now owns 768,970 shares of the medical instruments supplier’s stock valued at $71,883,000 after acquiring an additional 81,469 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Trading Down 1.1%

Shares of MMSI stock opened at $77.18 on Monday. The company has a current ratio of 4.34, a quick ratio of 2.95 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $4.59 billion, a price-to-earnings ratio of 36.41, a price-to-earnings-growth ratio of 2.23 and a beta of 0.61. Merit Medical Systems, Inc. has a 12-month low of $76.68 and a 12-month high of $107.27. The stock’s 50-day moving average price is $83.52 and its 200-day moving average price is $84.84.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. The business had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities research analysts predict that Merit Medical Systems, Inc. will post 3.37 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on MMSI shares. Barrington Research raised their target price on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Piper Sandler lowered their target price on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. Zacks Research downgraded shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Merit Medical Systems presently has an average rating of “Moderate Buy” and an average target price of $103.33.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.